Khalaf H
Department of Liver Transplantation and Hepatobiliary-Pancreatic Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Transplant Proc. 2010 Apr;42(3):865-70. doi: 10.1016/j.transproceed.2010.02.037.
Vascular complications (VC) after liver transplantation (OLT) are one of the most feared problems that frequently result in graft and patient loss. Herein we have reported our experience with VC after either deceased donor liver transplantation (DDLT) or living donor liver transplantation (LDLT).
Between April 2001 and September 2009, we performed 224 OLT: 155 DDLT and 69 LDLT. The overall male/female ratio was 136/88 and the adult/pediatric ratio was 208/16. We retrospectively identified and analyzed vascular complications in both groups.
In the DDLT group, 11/155 recipients (7%) suffered vascular complications; hepatic artery thrombosis (HAT; n=5; 3.2%), portal vein thrombosis occurred (n=4; 2.6%); hepatic vein stenosis (n=1; 0.6%), and severe postoperative bleeding due to a slipped splenic artery ligature (n=1, 0.6%). In the DDLT group, 4/11 (36.4%) patients died as a direct result of the vascular complications. In the LDLT group, 9/69 recipients (13%) suffered vascular complications: HAT (n=3; 4.3%), portal vein problems (n=5; 7.2%), and hepatic vein stenosis (n=1; 1.5%). Among LDLT, 3/9 (33.3%) patients died as a direct result of the vascular complications. In both groups vascular complications were associated with poorer patient and graft survival.
In our experience, the incidence of vascular complications was significantly higher among the LDLT group compared with the DDLT group. Vascular complications were associated with poorer graft and patient survival rates in both groups.
肝移植(OLT)后的血管并发症(VC)是最令人担忧的问题之一,常常导致移植物丢失和患者死亡。在此,我们报告了我们在尸体供肝肝移植(DDLT)或活体供肝肝移植(LDLT)后处理血管并发症的经验。
2001年4月至2009年9月期间,我们共进行了224例肝移植手术:155例尸体供肝肝移植和69例活体供肝肝移植。总体男女比例为136/88,成人/儿童比例为208/16。我们对两组患者的血管并发症进行了回顾性鉴定和分析。
结果:在尸体供肝肝移植组中,11/155例受者(7%)出现血管并发症;肝动脉血栓形成(HAT;n = 5;3.2%),门静脉血栓形成(n = 4; 2.6%);肝静脉狭窄(n = 1;0.6%),以及因脾动脉结扎线滑脱导致的严重术后出血(n = 1,0.6%)。在尸体供肝肝移植组中,4/11(36.4%)例患者直接死于血管并发症。在活体供肝肝移植组中,9/69例受者(13%)出现血管并发症:肝动脉血栓形成(n = 3;4.3%),门静脉问题(n = 5;7.2%),以及肝静脉狭窄(n = 1;1.5%)。在活体供肝肝移植组中,3/9(33.3%)例患者直接死于血管并发症。两组中,血管并发症均与患者及移植物的较差生存率相关。
根据我们的经验,活体供肝肝移植组血管并发症的发生率显著高于尸体供肝肝移植组。两组中,血管并发症均与移植物及患者的较差生存率相关。